Press Releases

Date	Title	Company
06-Dec-2023	Neue Post-Hoc-Analyse von Phase-3-Daten zeigt, dass AJOVY® (Fremanezumab) Migräneattacken bei Erwachsenen mit Migräne und komorbider Adipositas reduziert	Businesswire
06-Dec-2023	BioStar Capital Closes Fund V at $130.3 Million, Surpassing Previous Funds	Businesswire
06-Dec-2023	ThreatNG Launches Groundbreaking Open-Source Governance and Compliance Dataset Project	Businesswire
06-Dec-2023	Schwarzman Scholars Announces Class of 2024-2025	Businesswire
06-Dec-2023	Lubrizol’s 2023 Innovations Advanced Mobility, Improved Wellbeing and Enhanced Modern Life	Businesswire
06-Dec-2023	BioAlberta Announces Partnership with Lawcubator Technologies	Businesswire
06-Dec-2023	Global Abdominal Drainage Tubes Strategic Research Report 2023 - ResearchAndMarkets.com	Businesswire
06-Dec-2023	Taiwan Bio and TRACT Therapeutics, Inc. Announce Strategic Partnership to Advance a Novel Therapeutic Approach for Preventing Rejection in Solid Organ Transplant	Businesswire
06-Dec-2023	Une nouvelle analyse post hoc des données de phase 3 montre qu’AJOVY® (fremanezumab) réduit les crises de migraine chez les adultes souffrant de migraine et d’obésité comorbide	Businesswire
06-Dec-2023	MyMD Pharmaceuticals Plans FDA-Cleared Phase 2 Clinical Trial of MYMD-1 in Rheumatoid Arthritis	Businesswire
06-Dec-2023	bit.bio further expands ioCells™️ range with early access launch of ioMotor Neurons™️ for research and drug discovery in diseases such as amyotrophic lateral sclerosis (ALS)	Businesswire
06-Dec-2023	Catawba Research Partners With Elligo Health Research® to Expand Access and Simplify Clinical Research Participation	Businesswire
06-Dec-2023	Riassunto: Una nuova analisi a posteriori dei dati di fase 3 dimostra come AJOVY® (fremanezumab) consenta di ridurre gli attacchi di emicrania in adulti soggetti ad emicranie e con obesità come comorbilità	Businesswire
06-Dec-2023	NanoVibronix Featured in Your Bladder Health Magazine	Businesswire
06-Dec-2023	Resumen: Un nuevo análisis post hoc de datos de fase 3 muestra que AJOVY® (fremanezumab) redujo los ataques de migraña en adultos con migraña y obesidad comórbida	Businesswire
06-Dec-2023	Dr. Vijay Ivaturi Announced as New Chief Executive Officer at PumasAI	PumasAI
06-Dec-2023	IMIDomics and Bristol Myers Squibb Expand Long-Standing Partnership to Advance Immune-Mediated Inflammatory Disease Treatment Research and Development	Businesswire
06-Dec-2023	inTEST Continues Executing on Five-Point Strategy to Expand Geographically - Establishes Southeast Asia Center of Excellence in Malaysia	Businesswire
06-Dec-2023	Riverbed Survey: Ninety-Three Percent of Manufacturing Decision-Makers Believe They Need to Provide More Advanced Digital Experiences to Remain Competitive as Next Generation Employees Enter the Workforce	Businesswire
06-Dec-2023	IGC Pharma Announces Collaboration to Integrate AI into Clinical Trials	Businesswire